Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
Our selection of compounds is from a large virtual library of over 60 billion molecules. The production and distribution of these compounds are managed by our partner Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Several key aspects differentiate our library:
partner
Reaxense
upacc
Q96BN2
UPID:
TADA1_HUMAN
Alternative names:
SPT3-associated factor 42; Transcriptional adapter 1-like protein
Alternative UPACC:
Q96BN2; A8K4J9
Background:
Transcriptional adapter 1, also known as SPT3-associated factor 42 and Transcriptional adapter 1-like protein, plays a crucial role in the regulation of gene expression. Its involvement in transcriptional regulation suggests a fundamental role in cellular processes and developmental pathways.
Therapeutic significance:
Understanding the role of Transcriptional adapter 1 could open doors to potential therapeutic strategies. Its pivotal role in transcriptional regulation makes it a key target for research in gene expression-related disorders.